Home

Press Releases

12345678910
SWKS Deadline: Rosen Law Firm Urges Skyworks Solutions, Inc. (NASDAQ: SWKS) Stockholders to Contact the Firm for Information About Their Rights
Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of securities of Skyworks Solutions, Inc. (NASDAQ: SWKS) between July 30, 2024 and February 5, 2025. Skyworks describes itself as a “developer, manufacturer, and provider of analog and mixed-signal semiconductor products and solutions for numerous applications, including aerospace, automotive, broadband, cellular infrastructure, connected home, defense, entertainment and gaming, industrial, medical, smartphone, tablet, and wearables.”
By The Rosen Law Firm, P.A. · Via Business Wire · April 27, 2025
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Canopy Growth Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - CGC
NEW YORK, April 27, 2025 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · April 27, 2025
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages BigBear.ai Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BBAI
NEW YORK, April 27, 2025 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · April 27, 2025
Best Online Casino Bonuses in Canada 2025: High Value Offers, Low Wagering Terms, and Fast Payouts Analyzed
WireDaily's Top Picks for the Best Casino Bonuses Canadians Can Claim Right Now
Via ACCESS Newswire · April 27, 2025
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Bakkt Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BKKT
NEW YORK, April 27, 2025 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · April 27, 2025
Valnet Inc. and its CEO File Lawsuit Against The Wrap News Inc. for Defamation, Unfair Competition and Other Illegal Actions
Valnet Inc. (“Valnet”) and its Co-Founder and CEO, Hassan Youssef, have filed a lawsuit in the United States District Court for the District of Delaware against The Wrap News Inc. (“The Wrap”) for defamation, unfair competition and other illegal actions taken by The Wrap in connection with an article published by The Wrap on March 20, 2025 smearing Valnet and Mr. Youssef.
By Valnet Inc. · Via Business Wire · April 27, 2025
OLYMPUS Long-Term Follow-Up Study Reports Nearly Four-Year Duration of Response in Subset of Patients with Low-Grade Upper Tract Urothelial Cancer Who Achieved a Complete Response to Initial JELMYTO Treatment
UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights a duration of response of nearly four years from a long-term follow-up study with JELMYTO® (mitomycin) for pyelocalyceal solution, which is FDA-approved for the treatment of low-grade upper tract urothelial cancer (LG-UTUC) in adult patients.
By UroGen Pharma Ltd. · Via Business Wire · April 27, 2025
Banco de Chile Announces BCH Files 2024 20F Annual Report
SANTIAGO, CHILE / ACCESS Newswire / April 27, 2025 / Banco de Chile (NYSE:BCH) announced today the filing of its annual report on Form 20-F for the fiscal year ended December 31, 2024 (the "2024 Annual Report") with the U.S. Securities and Exchange Commission (the "SEC").
Via ACCESS Newswire · April 27, 2025
Studies Explore How New Treatments, Metabolic Health and Weight Loss Shape Sexual Wellness for Men and Women
LAS VEGAS, April 27, 2025 (GLOBE NEWSWIRE) -- Exciting new research unveiled at the American Urological Association (AUA) Annual Meeting in Las Vegas highlights the evolving landscape of sexual health and wellness for both men and women.
Precede Biosciences Presents Data at AACR 2025 Demonstrating Ability to Resolve Gene Expression for Thousands of Tumor-Specific Genes from a Simple Blood Test
BOSTON, April 27, 2025 (GLOBE NEWSWIRE) -- Precede Biosciences, a company impacting the development and use of precision medicines with a first-in-class comprehensive epigenomic liquid biopsy platform, today shared the company’s scientific presentation from the 2025 American Association for Cancer Research (AACR) Annual Meeting taking place from April 25 to 30, 2025, in Chicago, Illinois.
By Precede Biosciences, Inc. · Via GlobeNewswire · April 27, 2025
GRO Foundation Forms Strategic Alliance with Uganda's National Forestry Authority and Inter-Religious Council to Restore Mpanga Forest Reserve
GRO Foundation launches large-scale reforestation initiative in Uganda through new partnership, integrating environmental restoration with community-driven development.
Via ACCESS Newswire · April 27, 2025
Abpro and Celltrion Unveil Preclinical Data for ABP-102/CT-P72 at AACR 2025, Showcasing Potential Best-in-Class HER2 x CD3 T-Cell Engager
WOBURN, Mass., April 27, 2025 (GLOBE NEWSWIRE) -- Abpro Holdings, Inc. (Nasdaq:ABP) ("Abpro"), a biotechnology company dedicated to advancing next-generation antibody therapies for severe and life-threatening diseases, and Celltrion, a leading biopharmaceutical company, today unveiled preclinical data for ABP-102/CT-P72 in an oral presentation at the American Association for Cancer Research® (AACR) Annual Meeting 2025, in the New Drugs on the Horizon session.
By Abpro Corporation · Via GlobeNewswire · April 27, 2025
ZEX PR WIRE Announces Participation as Silver Sponsor at TOKEN2049 Dubai 2025
Dubai, UAE, April 27, 2025 — ZEX PR WIRE, the Read more
Via Zexprwire · April 27, 2025
Studies Link Lifestyle, Exercise and Yoga to Improved Urologic Health and Cancer Outcomes
LAS VEGAS, April 27, 2025 (GLOBE NEWSWIRE) -- Abstracts being presented at this year's American Urological Association (AUA) Annual Meeting in Las Vegas highlight the powerful role of healthy lifestyle choices in urologic health and cancer management.
Phixius by Nacha Expands Bank Account Validation Coverage With ValidiFI
Phixius by Nacha—a secure, peer-to-peer payment information network—announced today that ValidiFI is live on the Phixius network as an additional provider of bank account validation. Phixius now offers multiple providers of account validation, expanding the coverage of account validation data for Phixius users.
By Nacha · Via Business Wire · April 27, 2025
How a Secured Loan Can Help You Save Money
NEW YORK, NY / ACCESS Newswire / April 27, 2025 / If you're in the market to apply for a loan, it's helpful to understand what a secure loan is and how you use it to your advantage. A secured loan requires the borrower to pledge an asset, like a car, house, or savings account, as collateral. If the borrower defaults on the loan, the lender has the right to seize the collateral.
Via ACCESS Newswire · April 27, 2025
New Patient-Reported Outcomes from UGN-102 Clinical Trials Show the Investigational Treatment Did Not Adversely Affect Functionality, Symptom Burden, and Quality of Life in Patients with LG-IR-NMIBC
UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced patient-reported outcomes following treatment of patients with low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC) that showed investigational drug UGN-102 (mitomycin) for intravesical solution achieved robust and durable complete response (CR) rates without negatively impacting quality of life. The data (Moderated Poster - MP15) were presented at the AUA 2025 Annual Meeting in Las Vegas, Nevada.
By UroGen Pharma Ltd. · Via Business Wire · April 27, 2025
Young Heart Patients Receive Care Close to Home Thanks to Intermountain Health
Intermountain Health St. Vincent Regional Hospital is home to the only Pediatric Intensive Care Unit and Pediatric Surgery program in eastern Montana.
Via PRUnderground · April 27, 2025
New Long-Term Follow-Up Data from OPTIMA II Study of UGN-102 Demonstrates Median Duration of Response of Two Years in Patients with LG-IR-NMIBC
UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced new data from the OPTIMA II Phase 2b study of UGN‑102 (mitomycin) for intravesical solution demonstrate clinically meaningful two-year duration of response (24.2 months) by Kaplan-Meier analysis. UGN-102 is UroGen’s sustained-release formulation of mitomycin being developed for the treatment of recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC).
By UroGen Pharma Ltd. · Via Business Wire · April 27, 2025
MidAmerican Printing Systems Updates Chicago Digital Printing Services in IL
Schiller Park IL () April 27, 2025 -- A Chicago digital printer introduces updated digital printing services designed for efficiency and quality for clients in Illinois.
Via Prodigy · April 27, 2025
Cement and Natural Stone Tile Collections Handcrafted by Sabine Hill in Hartland, WI
Hartland () April 27, 2025 -- Sabine Hill's new tile shop introduces handcrafted design solutions to Midwest homes and professionals.
Via Prodigy · April 27, 2025
Big Mikes Gutters Launches New Website for Gutter Guards in Minneapolis, MN
Minneapolis, MN () April 27, 2025 -- The Minneapolis-based gutter company offers high-quality gutter guards for homes and businesses across the city.
Via Prodigy · April 27, 2025
Chicagoland Youth Basketball Network Opens Registration for May Tournaments
Chicago IL () April 27, 2025 -- Chicagoland Youth Basketball Network opens registration for thrilling 2-game and 3-game tournaments starting this May.
Via Prodigy · April 27, 2025
PRVC Systems Installs Hospital Curtain Tracks in High-Traffic Medical Spaces in Wilmette, IL
Wilmette IL () April 27, 2025 -- PRVC Systems transforms how healthcare facilities manage privacy through innovative solutions that enhance patient safety and spatial flexibility.
Via Prodigy · April 27, 2025
Assist Roofing Expands Metal Roofing Services to Offer Fortified Protection for Coastal Homes In NC
Washington, NC () April 27, 2025 -- Assist Roofing enhances metal roofing services with fortified certification, helping owners in NC gain advanced storm-ready solutions.
Via Prodigy · April 27, 2025
Blinka Optical Offers Services to Walk-Ins at Geneva Eyeglasses Location
Geneva, IL () April 27, 2025 -- Blinka Optical opens its eye exams and eyewear services to customers who walk in its shop in Geneva, IL.
Via Prodigy · April 27, 2025
Limestone Moving Co. Expands Moving Services Across Austin, TX
Austin, TX () April 27, 2025 -- One of Austin’s most trusted moving companies announces broader coverage and service enhancements to better support residential and commercial clients.
Via Prodigy · April 27, 2025
Stark Moving & Storage Expands Local and Long-Distance Moving Services to Dedham
Framingham, MA () April 27, 2025 -- Framingham-based movers bring their expertise to new locations in Dedham, providing reliable moving services to new customers.
Via Prodigy · April 27, 2025
Stark Moving and Storage Scales Movers in Dedham to Meet Rising Demand
Dedham, MA () April 27, 2025 -- Stark Moving and Storage enhances moving services across Dedham amid the push of new market opportunities.
Via Prodigy · April 27, 2025
Stark Moving & Storage Worcester Expands Services to Worcester, MA
Worcester, MA () April 27, 2025 -- Stark Moving & Storage is proud to announce its expansion into Worcester, MA, providing reliable moving and storage solutions for both local and long-distance customers.
Via Prodigy · April 27, 2025
Stark Moving and Storage Expands Moving Solutions to Waltham
Waltham, MA () April 27, 2025 -- Enhanced capabilities position Stark Moving and Storage as Waltham’s premier choice for long-distance relocations.
Via Prodigy · April 27, 2025
Price Right Supplies Fort Worth With High-Quality Trees From Oklahoma Tree Farm
Haslet, TX () April 27, 2025 -- Discerning buyers rely on Price Right Professional Landscaping & Tree Service for high-quality trees that thrive in Texas.
Via Prodigy · April 27, 2025
GERN Deadline: Rosen Law Firm Urges Geron Corporation (NASDAQ: GERN) Stockholders to Contact the Firm for Information About Their Rights
Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers and acquirers of Geron Corporation (NASDAQ: GERN) securities between February 28, 2024 and February 25, 2025. Geron is a commercial-stage biopharmaceutical company.
By The Rosen Law Firm, P.A. · Via Business Wire · April 27, 2025
11th Gulangyu Poetry Festival Opens with Flair
Starting this weekend, the annual poetry ceremony–the 11th Gulangyu Poetry Festival–arrives as scheduled, heralding the opening of a romantic chapter of verses from across the sea. From April 26 to May 2, Gulangyu, the Piano Island will be steeped in poetic ambiance. Prominent literary figures including famous writer and “People’s Artist” Wang Meng, renowned poets Shu Ting and Zang Di, experts and scholars from institutions including Peking University, as well as poet representatives from France, Italy, Russia, Spain, Colombia, Argentina, and other countries, will join poetry enthusiasts for a poetic rendezvous, sharing a feast of poetic culture and their reflections on poetry and the world.
Via Binary News Network · April 27, 2025
KEYTRUDA® (pembrolizumab) as Perioperative Treatment With Standard of Care (SOC) Adjuvant Therapy Significantly Improved Event-Free Survival Compared to SOC Alone in Patients With Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced results from the Phase 3 KEYNOTE-689 trial evaluating KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 therapy, as a perioperative treatment regimen for patients with stage III or IVA, resected, locally advanced head and neck squamous cell carcinoma (LA-HNSCC). Results at the first interim analysis of the trial showed KEYTRUDA significantly improved event-free survival (EFS) as part of a perioperative treatment regimen with adjuvant standard of care (SOC) radiotherapy with or without cisplatin compared to adjuvant standard of care (SOC) radiotherapy with or without cisplatin alone in patients with resectable LA-HNSCC. These data are being presented for the first time today during a Plenary Session at the American Association for Cancer Research (AACR) Annual Meeting 2025 (Abstract #CT001) and were selected for the AACR press program.
By Merck & Co., Inc. · Via Business Wire · April 27, 2025
100X MEMEBOX Launches to Redefine Wealth Building in Crypto
100X has officially launched one of its most powerful and forward-thinking ecosystem products to date—100X MEMEBOX—marking a bold leap into the future of structured, trend-driven wealth generation in the crypto space. In an industry where investors are constantly torn between risk and security, 100X MEMEBOX offers a fresh, intelligent approach: giving users access to market upside while eliminating the complexity of day-to-day trading.
Via GlobePRwire · April 27, 2025
FLNC Deadline: Rosen Law Firm Urges Fluence Energy, Inc. (NASDAQ: FLNC) Stockholders to Contact the Firm for Information About Their Rights
Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of common stock of Fluence Energy, Inc. (NASDAQ: FLNC) between November 29, 2023 and February 10, 2025. Fluence describes itself as a company that “offers energy storage products and solutions, delivery services, recurring operational and maintenance services, and digital applications and solutions for energy storage and other power assets.”
By The Rosen Law Firm, P.A. · Via Business Wire · April 27, 2025
ARCFOX Unveils T1 and 2025 ARCFOX Alpha S5 ULTRA at Auto Shanghai 2025, Featuring Deep Integration of DeepSeek Intelligent System
Shanghai, China--(Newsfile Corp. - April 27, 2025) - At the 21st Shanghai International Automobile Industry Exhibition (Auto Shanghai 2025), ARCFOX,...
Via Newsfile · April 27, 2025
RC Deadline: Rosen Law Firm Urges Ready Capital Corporation (NYSE: RC) Stockholders to Contact the Firm for Information About Their Rights
Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of common stock of Ready Capital Corporation (NYSE: RC) between November 7, 2024 and March 2, 2025. Ready Capital describes itself as a real estate finance company.
By The Rosen Law Firm, P.A. · Via Business Wire · April 27, 2025
Lead Plaintiff Deadline on May 12, 2025 for GERN Investors - Kessler Topaz Meltzer & Check, LLP Encourages Investors with Losses to Contact the Firm
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that securities class action lawsuits have been filed against Geron Corporation (“Geron”) (NASDAQ: GERN) on behalf of those who purchased or otherwise acquired Geron securities between February 28, 2024, and February 25, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is May 12, 2025.
Swimlane Ranks ‘Most Valuable Pioneer’ in SecOps AI
Swimlane, AI hyperautomation for the entire security organization, today announced it has been named the “Most Valuable Pioneer” in AI maturity by QKS Group. In the 2025 QKS AI Maturity Matrix™, Swimlane ranks ahead of seven other vendors for its AI-first productization, advanced vision and agentic AI roadmap. Swimlane is ranked ahead of Palo Alto Networks, Cisco, D3, Tines, Fortinet, Torq and Anomali.
By Swimlane · Via Business Wire · April 27, 2025
Studies Showcase Women’s and Children’s Bladder Health—From Early Symptoms to Innovative Treatments
LAS VEGAS, April 27, 2025 (GLOBE NEWSWIRE) -- Abstracts presented at this year's American Urological Association (AUA) Annual Meeting in Las Vegas highlight advances in women’s and pediatric urology.
SpringWorks Therapeutics Announces Expected CHMP Opinion in Q2 2025 for Nirogacestat for the Treatment of Adults with Desmoid Tumors in the European Union
STAMFORD, Conn., April 27, 2025 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, announced today that the Company anticipates the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) will adopt an opinion on the marketing authorization application (MAA) for nirogacestat, an oral gamma secretase inhibitor, for the treatment of adults with desmoid tumors in the second quarter of 2025.
By SpringWorks Therapeutics, Inc. · Via GlobeNewswire · April 27, 2025
California Realtors Are Turning to Circle to Simplify Transactions, Improve Communication, and Close Deals Faster
The groundbreaking AI-powered platform is transforming how real estate transactions are managed, ensuring faster closings, fewer disputes, and greater efficiency for all stakeholders involved.
MRVI Deadline: Rosen Law Firm Urges Maravai Lifesciences Holdings, Inc. (NASDAQ: MRVI) Stockholders to Contact the Firm for Information About Their Rights
Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of securities of Maravai Lifesciences Holdings, Inc. (NASDAQ: MRVI) between August 7, 2024 and February 24, 2025. Maravai is a life sciences company which provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases worldwide.
By The Rosen Law Firm, P.A. · Via Business Wire · April 27, 2025
TFII Deadline: Rosen Law Firm Urges TFI International Inc. (NYSE: TFII) Stockholders to Contact the Firm for Information About Their Rights
Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of securities of TFI International Inc. (NYSE: TFII) between April 26, 2024 and February 19, 2025. TFI International is a transportation and logistics company.
By The Rosen Law Firm, P.A. · Via Business Wire · April 27, 2025
Renegade Insurance Welcomes Matt Gaby as New Franchise Owner
United States, April 27, 2025 -- Renegade Insurance is thrilled to announce Matt Gaby as the newest franchise owner in their rapidly growing national network. With deep roots in the Columbus community, Matt is set to build a large, high-performing agency that combines the latest technology with the personalized service local customers trust.
RKLB Deadline: Rosen Law Firm Urges Rocket Lab USA, Inc. (NASDAQ: RKLB) Stockholders to Contact the Firm for Information About Their Rights
Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of securities of Rocket Lab USA, Inc. (NASDAQ: RKLB) between November 12, 2024 and February 25, 2025. Rocket Lab describes itself as a “space company which provides launch services, spacecraft design services, spacecraft components, spacecraft manufacturing and other spacecraft and on-orbit management solutions.”
By Rosen Law Firm · Via Business Wire · April 27, 2025
Risk Strategies acquires GMC Advisors, LLC
Texas-based commercial lines agency adds to construction, manufacturing, and energy industry expertise
By Risk Strategies · Via GlobeNewswire · April 27, 2025
ELF Deadline: Rosen Law Firm Urges e.l.f. Beauty, Inc. (NYSE: ELF) Stockholders to Contact the Firm for Information About Their Rights
Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of securities of e.l.f. Beauty, Inc. (“Elf”) (NYSE: ELF) between November 1, 2023 and November 19, 2024. Elf describes itself as a company that “provides cosmetic and skin care products.”
By The Rosen Law Firm, P.A. · Via Business Wire · April 27, 2025